Global MRI Safe Biopsy Needle Market Overview
Western Market Research estimates that the Global MRI Safe Biopsy Needle Market was valued at USD XXXX million in 2025 and is projected to reach USD XXXX million by 2036, growing at a CAGR of XX% during the forecast period 2026–2036.
MRI safe biopsy needles are non-ferromagnetic, image-compatible interventional devices designed for tissue sampling under magnetic resonance imaging guidance. These needles enable high-precision targeting of soft-tissue lesions, particularly in breast, prostate, brain, and musculoskeletal applications, where MRI provides superior contrast resolution compared to other imaging modalities.
Market growth is driven by the rising adoption of MRI-guided biopsies, increasing cancer incidence, demand for minimally invasive diagnostics, and continuous innovation in titanium, polymer-based, and artifact-minimizing needle designs. Expansion of advanced diagnostic imaging infrastructure globally further supports market demand.
Impact of COVID-19 on the MRI Safe Biopsy Needle Market
The COVID-19 pandemic temporarily disrupted elective diagnostic procedures due to imaging center closures and reduced patient visits. However, recovery was supported by:
-
Resumption of delayed oncology diagnostics
-
Increased prioritization of early and accurate cancer detection
-
Renewed investments in advanced imaging and interventional radiology
Post-pandemic, demand stabilized with a renewed focus on precision diagnostics and minimally invasive procedures.
Global MRI Safe Biopsy Needle Market Segmentation
By Product Type
-
Fine Needle Biopsy (FNB) Needles
-
Core Needle Biopsy (CNB) Needles
-
Vacuum-Assisted Biopsy (VAB) Needles
By Material
-
Titanium Alloys
-
Non-Ferromagnetic Stainless Steel
-
Advanced Polymer & Composite Materials
By Imaging Compatibility
-
MRI-Only Compatible
-
Multi-Modality Compatible (MRI/CT/US)
By Application
-
Hospitals
-
Ambulatory Surgical Centers
-
Research & Academic Institutes
-
Specialty Diagnostic Centers
Regional Analysis
North America
-
Largest market driven by high MRI penetration and cancer screening rates
-
Strong adoption of MRI-guided breast and prostate biopsies
-
Favorable reimbursement for advanced diagnostic procedures
Europe
-
Widespread use of MRI in oncology diagnostics
-
Strong regulatory focus on device safety and image compatibility
-
Growth in academic and research-driven biopsy procedures
Asia-Pacific
-
Fastest-growing region
-
Rapid expansion of MRI infrastructure
-
Rising cancer incidence and diagnostic awareness
South America
-
Gradual growth supported by private diagnostic centers
-
Increasing adoption of minimally invasive biopsy techniques
Middle East & Africa
-
Growth led by tertiary hospitals and medical tourism
-
Improving access to advanced imaging technologies
Competitive Landscape – Key Market Players
Competition is based on MRI compatibility, image artifact reduction, sampling accuracy, and procedural safety. Key players include:
-
Olympus
-
Hologic
-
Argon Medical Devices
-
Somatex Medical Technologies
-
BD
-
Sterylab
-
Cook Medical
-
Merit Medical Systems
-
Bard Medical
Porter’s Five Forces Analysis
-
Threat of New Entrants: Medium – regulatory and material-science barriers
-
Bargaining Power of Suppliers: Moderate – specialized non-ferromagnetic materials
-
Bargaining Power of Buyers: High – hospital and imaging-center procurement power
-
Threat of Substitutes: Low – MRI-guided biopsy requires MRI-safe devices
-
Competitive Rivalry: Moderate to High – innovation and compatibility differentiation
SWOT Analysis
Strengths
-
Essential for MRI-guided diagnostics
-
High precision and safety profile
-
Growing clinical acceptance
Weaknesses
-
Higher cost compared to standard biopsy needles
-
Limited availability in low-resource settings
Opportunities
-
Expansion of MRI-guided oncology diagnostics
-
Growth in prostate and breast cancer screening
-
Development of multi-modality compatible needles
Threats
-
Pricing pressure from healthcare providers
-
Competition from alternative imaging-guided biopsy methods
Trend Analysis
-
Increasing adoption of MRI-guided breast and prostate biopsies
-
Development of artifact-free and multi-modality needles
-
Growth in vacuum-assisted MRI biopsy systems
-
Integration with robotic and navigation-guided biopsy platforms
-
Rising use in academic and research institutions
Market Drivers & Challenges
Key Drivers
-
Rising cancer prevalence and early diagnosis initiatives
-
Superior soft-tissue contrast of MRI imaging
-
Shift toward minimally invasive diagnostic procedures
Key Challenges
-
High procedural and equipment costs
-
Limited MRI access in developing regions
-
Training requirements for MRI-guided interventions
Value Chain Analysis
-
Non-Ferromagnetic Raw Material Sourcing
-
Precision Needle Design & Manufacturing
-
Sterilization & Regulatory Certification
-
Distribution to Hospitals & Imaging Centers
-
Clinical Use in MRI-Guided Biopsy Procedures
Strategic Recommendations for Stakeholders
-
Manufacturers: Focus on artifact-reduction technology and multi-modality compatibility
-
Hospitals & Imaging Centers: Expand MRI-guided biopsy capabilities for oncology care
-
Investors: Target Asia-Pacific MRI infrastructure growth
-
Researchers: Develop next-generation polymer-based MRI-safe biopsy tools
-
Policy Makers: Support reimbursement for advanced diagnostic biopsy procedures
1. Market Overview of MRI Safe Biopsy Needle
1.1 MRI Safe Biopsy Needle Market Overview
1.1.1 MRI Safe Biopsy Needle Product Scope
1.1.2 Market Status and Outlook
1.2 MRI Safe Biopsy Needle Market Size by Regions: 2015 VS 2021 VS 2026
1.3 MRI Safe Biopsy Needle Historic Market Size by Regions
1.4 MRI Safe Biopsy Needle Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact MRI Safe Biopsy Needle Sales Market by Type
2.1 Global MRI Safe Biopsy Needle Historic Market Size by Type
2.2 Global MRI Safe Biopsy Needle Forecasted Market Size by Type
2.3 Fine Needle Biopsy
2.4 Core Needle Biopsy
2.5 Vacuum Assisted Biopsy
3. Covid-19 Impact MRI Safe Biopsy Needle Sales Market by Application
3.1 Global MRI Safe Biopsy Needle Historic Market Size by Application
3.2 Global MRI Safe Biopsy Needle Forecasted Market Size by Application
3.3 Hospitals
3.4 Research and Academic Institutes
3.5 Ambulatory Surgery Centers
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global MRI Safe Biopsy Needle Production Capacity Market Share by Manufacturers
4.2 Global MRI Safe Biopsy Needle Revenue Market Share by Manufacturers
4.3 Global MRI Safe Biopsy Needle Average Price by Manufacturers
5. Company Profiles and Key Figures in MRI Safe Biopsy Needle Business
5.1 Olympus
5.1.1 Olympus Company Profile
5.1.2 Olympus MRI Safe Biopsy Needle Product Specification
5.1.3 Olympus MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
5.2 Hologic
5.2.1 Hologic Company Profile
5.2.2 Hologic MRI Safe Biopsy Needle Product Specification
5.2.3 Hologic MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
5.3 Argon Medical Devices
5.3.1 Argon Medical Devices Company Profile
5.3.2 Argon Medical Devices MRI Safe Biopsy Needle Product Specification
5.3.3 Argon Medical Devices MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
5.4 Somatex Medical Technologies
5.4.1 Somatex Medical Technologies Company Profile
5.4.2 Somatex Medical Technologies MRI Safe Biopsy Needle Product Specification
5.4.3 Somatex Medical Technologies MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
5.5 BD
5.5.1 BD Company Profile
5.5.2 BD MRI Safe Biopsy Needle Product Specification
5.5.3 BD MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
5.6 Sterylab
5.6.1 Sterylab Company Profile
5.6.2 Sterylab MRI Safe Biopsy Needle Product Specification
5.6.3 Sterylab MRI Safe Biopsy Needle Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America MRI Safe Biopsy Needle Market Size
6.2 North America MRI Safe Biopsy Needle Key Players in North America
6.3 North America MRI Safe Biopsy Needle Market Size by Type
6.4 North America MRI Safe Biopsy Needle Market Size by Application
7. East Asia
7.1 East Asia MRI Safe Biopsy Needle Market Size
7.2 East Asia MRI Safe Biopsy Needle Key Players in North America
7.3 East Asia MRI Safe Biopsy Needle Market Size by Type
7.4 East Asia MRI Safe Biopsy Needle Market Size by Application
8. Europe
8.1 Europe MRI Safe Biopsy Needle Market Size
8.2 Europe MRI Safe Biopsy Needle Key Players in North America
8.3 Europe MRI Safe Biopsy Needle Market Size by Type
8.4 Europe MRI Safe Biopsy Needle Market Size by Application
9. South Asia
9.1 South Asia MRI Safe Biopsy Needle Market Size
9.2 South Asia MRI Safe Biopsy Needle Key Players in North America
9.3 South Asia MRI Safe Biopsy Needle Market Size by Type
9.4 South Asia MRI Safe Biopsy Needle Market Size by Application
10. Southeast Asia
10.1 Southeast Asia MRI Safe Biopsy Needle Market Size
10.2 Southeast Asia MRI Safe Biopsy Needle Key Players in North America
10.3 Southeast Asia MRI Safe Biopsy Needle Market Size by Type
10.4 Southeast Asia MRI Safe Biopsy Needle Market Size by Application
11. Middle East
11.1 Middle East MRI Safe Biopsy Needle Market Size
11.2 Middle East MRI Safe Biopsy Needle Key Players in North America
11.3 Middle East MRI Safe Biopsy Needle Market Size by Type
11.4 Middle East MRI Safe Biopsy Needle Market Size by Application
12. Africa
12.1 Africa MRI Safe Biopsy Needle Market Size
12.2 Africa MRI Safe Biopsy Needle Key Players in North America
12.3 Africa MRI Safe Biopsy Needle Market Size by Type
12.4 Africa MRI Safe Biopsy Needle Market Size by Application
13. Oceania
13.1 Oceania MRI Safe Biopsy Needle Market Size
13.2 Oceania MRI Safe Biopsy Needle Key Players in North America
13.3 Oceania MRI Safe Biopsy Needle Market Size by Type
13.4 Oceania MRI Safe Biopsy Needle Market Size by Application
14. South America
14.1 South America MRI Safe Biopsy Needle Market Size
14.2 South America MRI Safe Biopsy Needle Key Players in North America
14.3 South America MRI Safe Biopsy Needle Market Size by Type
14.4 South America MRI Safe Biopsy Needle Market Size by Application
15. Rest of the World
15.1 Rest of the World MRI Safe Biopsy Needle Market Size
15.2 Rest of the World MRI Safe Biopsy Needle Key Players in North America
15.3 Rest of the World MRI Safe Biopsy Needle Market Size by Type
15.4 Rest of the World MRI Safe Biopsy Needle Market Size by Application
16 MRI Safe Biopsy Needle Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Global MRI Safe Biopsy Needle Market Segmentation
By Product Type
-
Fine Needle Biopsy (FNB) Needles
-
Core Needle Biopsy (CNB) Needles
-
Vacuum-Assisted Biopsy (VAB) Needles
By Material
-
Titanium Alloys
-
Non-Ferromagnetic Stainless Steel
-
Advanced Polymer & Composite Materials
By Imaging Compatibility
-
MRI-Only Compatible
-
Multi-Modality Compatible (MRI/CT/US)
By Application
-
Hospitals
-
Ambulatory Surgical Centers
-
Research & Academic Institutes
-
Specialty Diagnostic Centers
Competitive Landscape – Key Market Players
Competition is based on MRI compatibility, image artifact reduction, sampling accuracy, and procedural safety. Key players include:
-
Olympus
-
Hologic
-
Argon Medical Devices
-
Somatex Medical Technologies
-
BD
-
Sterylab
-
Cook Medical
-
Merit Medical Systems
-
Bard Medical
